Janus Henderson Group’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $97.5M | Sell |
776,070
-7,896
| -1% | -$992K | 0.05% | 266 |
|
|
2025
Q1 | $88.7M | Sell |
783,966
-10,152
| -1% | -$1.15M | 0.05% | 280 |
|
|
2024
Q4 | $108M | Buy |
794,118
+1,922
| +0.2% | +$262K | 0.06% | 267 |
|
|
2024
Q3 | $91.3M | Sell |
792,196
-179,007
| -18% | -$20.6M | 0.05% | 290 |
|
|
2024
Q2 | $134M | Sell |
971,203
-407,310
| -30% | -$56.1M | 0.07% | 228 |
|
|
2024
Q1 | $190M | Sell |
1,378,513
-172,854
| -11% | -$23.8M | 0.1% | 187 |
|
|
2023
Q4 | $204M | Sell |
1,551,367
-165,687
| -10% | -$21.8M | 0.12% | 182 |
|
|
2023
Q3 | $193M | Sell |
1,717,054
-191,790
| -10% | -$21.6M | 0.13% | 173 |
|
|
2023
Q2 | $180M | Sell |
1,908,844
-85,677
| -4% | -$8.08M | 0.11% | 184 |
|
|
2023
Q1 | $202M | Sell |
1,994,521
-421,117
| -17% | -$42.6M | 0.13% | 163 |
|
|
2022
Q4 | $289M | Sell |
2,415,638
-7,438,030
| -75% | -$888M | 0.21% | 123 |
|
|
2022
Q3 | $1.05B | Buy |
9,853,668
+4,639,934
| +89% | +$493M | 0.39% | 58 |
|
|
2022
Q2 | $508M | Sell |
5,213,734
-1,096,029
| -17% | -$107M | 0.35% | 68 |
|
|
2022
Q1 | $592M | Sell |
6,309,763
-1,136,076
| -15% | -$107M | 0.29% | 79 |
|
|
2021
Q4 | $634M | Sell |
7,445,839
-1,540,472
| -17% | -$131M | 0.26% | 86 |
|
|
2021
Q3 | $862M | Buy |
8,986,311
+34,237
| +0.4% | +$3.28M | 0.38% | 57 |
|
|
2021
Q2 | $871M | Sell |
8,952,074
-279,215
| -3% | -$27.2M | 0.37% | 58 |
|
|
2021
Q1 | $898M | Buy |
9,231,289
+70,148
| +0.8% | +$6.82M | 0.41% | 52 |
|
|
2020
Q4 | $878M | Buy |
9,161,141
+2,612,748
| +40% | +$250M | 0.41% | 56 |
|
|
2020
Q3 | $630M | Buy |
6,548,393
+54,202
| +0.8% | +$5.21M | 0.33% | 66 |
|
|
2020
Q2 | $792M | Sell |
6,494,191
-1,135,008
| -15% | -$138M | 0.44% | 42 |
|
|
2020
Q1 | $660M | Buy |
7,629,199
+255,687
| +3% | +$22.1M | 0.45% | 45 |
|
|
2019
Q4 | $793M | Sell |
7,373,512
-1,130,024
| -13% | -$121M | 0.41% | 53 |
|
|
2019
Q3 | $766M | Sell |
8,503,536
-848,704
| -9% | -$76.5M | 0.42% | 56 |
|
|
2019
Q2 | $790M | Buy |
9,352,240
+540,279
| +6% | +$45.6M | 0.43% | 46 |
|
|
2019
Q1 | $776M | Buy |
8,811,961
+4,547
| +0.1% | +$401K | 0.43% | 46 |
|
|
2018
Q4 | $629M | Buy |
8,807,414
+1,644,949
| +23% | +$117M | 0.4% | 51 |
|
|
2018
Q3 | $881M | Sell |
7,162,465
-252,396
| -3% | -$31M | 0.47% | 36 |
|
|
2018
Q2 | $728M | Sell |
7,414,861
-49,133
| -0.7% | -$4.83M | 0.42% | 46 |
|
|
2018
Q1 | $619M | Buy |
7,463,994
+1,691,883
| +29% | +$140M | 0.36% | 61 |
|
|
2017
Q4 | $448M | Buy |
5,772,111
+264,348
| +5% | +$20.5M | 0.27% | 96 |
|
|
2017
Q3 | $338M | Buy |
5,507,763
+140,639
| +3% | +$8.62M | 0.22% | 132 |
|
|
2017
Q2 | $247M | Buy |
+5,367,124
| New | +$247M | 0.17% | 166 |
|